Back

Meta-analysis of duration of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention

European Journal of Preventive Cardiology

29 August 2020
Organised by: Logo
Read full article
ESC Journals

Contributors

Safi U Khan
Safi U Khan

Author

Guthrie Clinic Sayre , United States of America

Irbaz Bin Riaz
Irbaz Bin Riaz

Author

Hammad Rahman
Hammad Rahman

Author

Ahmed N Lone
Ahmed N Lone

Author

Munis Raza
Munis Raza

Author

Muhammad Shahzeb Khan
Muhammad Shahzeb Khan

Author

Anum Riaz
Anum Riaz

Author

Edo Kaluski
Edo Kaluski

Author

You may be interested in
thumbnail
Congress Presentation
Thirty-days versus standard duration of dual antiplatelet treatment after percutaneous coronary interventions: a systematic review and meta-analysis
27 August 2022
thumbnail
Webinar
Antithrombotic strategy for ACS: from default to alternative strategies. ESC 2023 Clinical Practice Guidelines - Webinar Series
28 November 2023
thumbnail
Congress Presentation
P2Y12 inhibitor monotherapy after short DAPT in acute coronary syndrome: a systematic review and meta-analysis
30 August 2024
thumbnail
Congress Presentation
Less bleeding by omitting aspirin in non-ST-segment elevation acute coronary syndrome patients (LEGACY)
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources